Viewing nowCombinationOlmesartan Medoxomil and Rosuvastatin Tablet 20/10 mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 202003964 · Approved 2020.05.28 · Insurance code 657807380
Treatment of hypertension and hypercholesterolemia, and reduction of cardiovascular disease risk
This medication is used for patients who need to take Olmesartan Medoxomil and Rosuvastatin together. Olmesartan Medoxomil helps effectively treat hypertension, especially essential hypertension. Rosuvastatin is mainly used as an adjunct treatment for lipid disorders such as hypercholesterolemia that are not improved by diet and exercise. Additionally, Rosuvastatin has a positive effect in slowing the progression of atherosclerosis and reducing the risk of cardiovascular diseases. It particularly helps decrease the risk of stroke, myocardial infarction, and revascularization procedures. Therefore, this medication is used for managing hypertension and hyperlipidemia, and for reducing cardiovascular disease risk.
The recommended initial dose of Olmesartan Medoxomil is 10 mg once daily, administered regardless of meals. If blood pressure is not adequately controlled, the dosage can be increased to 20 mg once daily, with a maximum dose of 40 mg per day. The antihypertensive effect typically appears within 2 weeks after initiating treatment, with maximum effectiveness occurring around 8 weeks. If blood pressure control is inadequate, adjunctive treatment with diuretics may be considered.
Safety and efficacy in children under 18 years have not been established.
This medication can cause serious harm to the fetus and newborn if administered to pregnant women in the second and third trimesters; therefore, it should be discontinued immediately if pregnancy is confirmed. This medication should not be administered to specific patients, including those with an allergy to this medication or its components, pregnant women or women of childbearing potential, nursing mothers, patients with severely impaired renal function, those with severe liver disease, bile duct obstruction, or muscle disorders. In patients with low blood pressure or low salt levels, hypotension may occur upon the initial administration of this medication, thus careful observation is required during administration. Patients with impaired kidney function, kidney transplant recipients, those with renovascular hypertension, or patients at risk of hyperkalemia should undergo regular monitoring of kidney function and serum potassium levels when receiving this medication. This medication may affect liver function, thus patients with a history of liver disease or elevated liver enzyme levels should undergo periodic liver function tests. Muscle pain or myopathy may occur, and rarely rhabdomyolysis may occur; therefore, if symptoms such as muscle pain, weakness, or cramps arise, consultation with a physician should be sought immediately. Caution should be exercised when this medication is used by patients who consume excessive alcohol or have a history of liver disease. Dizziness may occur due to blood pressure-lowering effects; thus, caution is advised during high-altitude work or when operating dangerous machinery, including driving. This medication may interact with other drugs, especially potassium-sparing diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, other antihypertensives, certain antibiotics, and antifungals; hence, inform your physician or pharmacist when taking these medications together. Women who are pregnant or breastfeeding should not use this medication, and women of childbearing potential should employ suitable contraceptive methods. Safety and efficacy in children under 18 years have not been established; therefore, avoid use in this age group. Elderly patients may have different metabolic rates and thus dosage adjustments and careful observation are necessary during administration. In the case of overdose, hypotension or heart abnormalities may occur, and immediate medical assistance should be sought; there is no specific antidote for this medication. This medication should be kept out of reach of children and should not be transferred to other containers.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling of the skin, oral/ocular mucosal pain, breathlessness or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice, profound lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination issues
Headache, dizziness, decreased sensation, drowsiness, gastroesophageal reflux, constipation, dental caries, dyspepsia, gastric ulcer, gastritis, gastroenteritis, musculoskeletal stiffness, atrial fibrillation, hypoglycemia, chest pain, rash, angioedema, weakness, vomiting, chronic malabsorption syndrome-like intestinal diseases, intestinal vascular edema, hyperkalemia, increased blood pressure, facial swelling, back pain, cough, nosebleed, upper respiratory tract infections, asthma, thrombocytopenia, hair loss, itching, arthralgia, arthritis, myopathy
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to keep it at a cool room temperature between 1 and 30 degrees Celsius.
White or yellowish round film-coated tablets
30 tablets/box [(10 tablets/Alu-Alu) × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.